Sangamo Therapeutics (LTS:0R1D) Float Percentage Of Total Shares Outstanding: 75.06% (As of Aug. 07, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0R1D Sangamo Therapeutics Inc LTS:0R1D
35 GF Score
Price $0.10
GF Value $0.19
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Sangamo Therapeutics Float Percentage Of Total Shares Outstanding?

Sangamo Therapeutics LTS:0R1D -9.01% 35 Float Percentage Of Total Shares Outstanding is 75.06% as of Aug. 07, 2026. GuruFocus rates LTS:0R1D with a GF Score™ of 35/100 and a GF Value™ of $0.19 (Possible Value Trap). The stock has 5 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Sangamo Therapeutics's float shares is 310.97 Mil. Sangamo Therapeutics's total shares outstanding is 414.29 Mil. Sangamo Therapeutics's float percentage of total shares outstanding is 75.06%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Sangamo Therapeutics's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Sangamo Therapeutics's Institutional Ownership is 2.02%.

LTS:0R1D
35GF Score
Sangamo Therapeutics Inc LTS:0R1D
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sangamo Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Sangamo Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=310.97/414.29
=75.06%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 75.06% mean?
Sangamo Therapeutics (LTS:0R1D) has a Float Percentage Of Total Shares Outstanding of 75.06% as of Aug. 07, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Sangamo Therapeutics and its competitors.
Is Sangamo Therapeutics' Float Percentage Of Total Shares Outstanding too high?
Sangamo Therapeutics' current Float Percentage Of Total Shares Outstanding is 75.06%. Overall, Sangamo Therapeutics has a GF Score™ of 35/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sangamo Therapeutics' Float Percentage Of Total Shares Outstanding compare to SER and ABVC?
Sangamo Therapeutics' Float Percentage Of Total Shares Outstanding of 75.06% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Sangamo Therapeutics and its competitors. Sangamo Therapeutics's current Float Percentage Of Total Shares Outstanding is 75.06%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sangamo Therapeutics stock overvalued right now?
Based on GuruFocus' analysis, Sangamo Therapeutics (LTS:0R1D) is currently considered Possible Value Trap. The stock's GF Value™ is $0.19, compared to a current price of $0.10 — trading 47.4% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 75.06%. Sangamo Therapeutics' overall GF Score™ is 35/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Sangamo Therapeutics (LTS:0R1D), the current Float Percentage Of Total Shares Outstanding is 75.06% as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sangamo Therapeutics (LTS:0R1D) Overvalued in 2026?

Based on GuruFocus' analysis, Sangamo Therapeutics stock appears to be undervalued. The current stock price of $0.10 is trading 47.4% below its estimated GF Value™ of $0.19. GuruFocus considers Sangamo Therapeutics to be Possible Value Trap.

Key valuation signals for LTS:0R1D:

  • Float Percentage Of Total Shares Outstanding: 75.06%
  • GF Value™: $0.19 vs. price of $0.10 (47.4% below fair value)
  • GF Score™: 35/100 with 5 warning signs

No single metric tells the full story. See the LTS:0R1D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sangamo Therapeutics Business Description

Other Exchanges SGMO:USAGBY:Germany
Address 501 Canal Boulevard, Richmond, CA, USA, 94804
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its neurology development is focused on two areas: development of epigenetic regulation therapies to treat serious neurological diseases and development of novel engineered adeno-associated virus, or AAV, capsids to deliver its therapies to the intended neurological targets. The group's pipeline products are Small Fiber Neuropathy, Prion Disease, Tauopathies, ALS/FTD, Huntington's Disease, Fabry Disease, and Hemophilia A.
35GF Score

Get the complete analysis for LTS:0R1D

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.10
Price
$0.19
GF Value